{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:16:54Z","timestamp":1786119414007,"version":"build-2736575974"},"reference-count":118,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2009,3]]},"DOI":"10.1097\/ppo.0b013e31819e31cf","type":"journal-article","created":{"date-parts":[[2010,1,27]],"date-time":"2010-01-27T01:19:34Z","timestamp":1264555174000},"page":"129-137","source":"Crossref","is-referenced-by-count":65,"title":["Histopathology of Hodgkin\u2019s Lymphoma"],"prefix":"10.1097","volume":"15","author":[{"given":"Franziska C.","family":"Eberle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haresh","family":"Mani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine S.","family":"Jaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210203","first-page":"68","article-title":"On some morbid experiences of the absorbent glands and spleen.","volume":"17","author":"Hodgkin\u2019s","year":"1832","journal-title":"Medicochirurgic Trans"},{"key":"R2-7-20210203","first-page":"56","article-title":"Cases of enlargement of the lymphatic glands and spleen (or Hodgkin\u2019s disease).","volume":"11","author":"Wilks","year":"1865","journal-title":"Guys Hosp Rep"},{"key":"R3-7-20210203","first-page":"133","article-title":"On the pathological changes in Hodgkins disease, with especial reference to its relation to tuberculosis.","volume":"1902","author":"Reed","year":"1902","journal-title":"Johns Hopkins Hosp Rep"},{"key":"R4-7-20210203","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S1092-9134(03)00020-0","article-title":"Whatever happened to Dorothy Reed?","volume":"7","author":"Dawson","year":"2003","journal-title":"Ann Diagn Pathol"},{"key":"R5-7-20210203","first-page":"381","article-title":"Malignant lymphoma: a clinico-pathologic survey of 618 cases.","volume":"18","author":"Gall","year":"1942","journal-title":"Am J Pathol"},{"key":"R6-7-20210203","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1056\/NEJM194407132310201","article-title":"Hodgkin\u2019s disease. II. Pathology.","volume":"231","author":"Jackson","year":"1944","journal-title":"N Engl J Med"},{"key":"R7-7-20210203","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/1097-0142(196603)19:3<317::AID-CNCR2820190304>3.0.CO;2-O","article-title":"Natural history of Hodgkin\u2019s disease as related to its patholgical picture.","volume":"19","author":"Lukes","year":"1966","journal-title":"Cancer"},{"key":"R8-7-20210203","first-page":"1311","article-title":"Report of the nomenclature committee.","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"R9-7-20210203","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1182\/blood.V84.5.1361.1361","article-title":"A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group.","volume":"84","author":"Harris","year":"1994","journal-title":"Blood"},{"key":"R10-7-20210203","article-title":"Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Jaffe","year":"2001"},{"key":"R11-7-20210203","article-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues.","author":"Swerdlow","year":"2008"},{"key":"R12-7-20210203","first-page":"701","article-title":"Expression of B-cell antigens by Hodgkin\u2019s and Reed-Sternberg cells.","volume":"139","author":"Schmid","year":"1991","journal-title":"Am J Pathol"},{"key":"R13-7-20210203","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1073\/pnas.91.23.10962","article-title":"Hodgkin\u2019s disease: Hodgkin\u2019s and Reed Sternberg cells picked from histological sections show clonal immunoglobulin gene rearrangements and appear to be derived from B cells at various stages of development.","volume":"91","author":"Kuppers","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"R14-7-20210203","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1097\/00000478-199405000-00014","article-title":"Nodular lymphocyte predominance Hodgkin\u2019s disease: a distinct clinico-pathological entity.","volume":"18","author":"Mason","year":"1994","journal-title":"Am J Surg Pathol"},{"key":"R15-7-20210203","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1080\/1042819021000006286","article-title":"Is classicalal Hodgkin\u2019s disease indeed a single entity?","volume":"43","author":"Levy","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"R16-7-20210203","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1002\/ijc.11005","article-title":"Hodgkin\u2019s disease etiology and novel viruses: clues from groups exposed to blood products.","volume":"104","author":"Glaser","year":"2003","journal-title":"Int J Cancer"},{"key":"R17-7-20210203","first-page":"260","article-title":"Epstein-Barr virus and other candidate viruses in the pathogenesis of Hodgkin\u2019s disease.","volume":"36","author":"Jarrett","year":"1999","journal-title":"Semin Hematol"},{"key":"R18-7-20210203","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1038\/sj.leu.2401097","article-title":"Epstein-Barr virus and Hodgkin\u2019s disease: further evidence for the three disease hypothesis.","volume":"12","author":"Armstrong","year":"1998","journal-title":"Leukemia"},{"key":"R19-7-20210203","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/(SICI)1096-9896(199708)182:4<475::AID-PATH878>3.0.CO;2-6","article-title":"Disappearance of the Epstein-Barr virus in a relapse of Hodgkin\u2019s disease.","volume":"182","author":"Delecluse","year":"1997","journal-title":"J Pathol"},{"key":"R20-7-20210203","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1016\/j.ejca.2006.05.012","article-title":"Hodgkin\u2019s disease incidence and survival in European children and adolescents (1978\u20131997): report from the Automated Cancer Information System project.","volume":"42","author":"Clavel","year":"2006","journal-title":"Eur J Cancer"},{"key":"R21-7-20210203","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1158\/1055-9965.EPI-04-0567","article-title":"Neighborhood socioeconomic status and Hodgkin\u2019s lymphoma incidence in California.","volume":"14","author":"Clarke","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R22-7-20210203","first-page":"4507","article-title":"Risk factors for nodular sclerosis and other types of Hodgkin\u2019s disease.","volume":"39","author":"Henderson","year":"1979","journal-title":"Cancer Res"},{"key":"R23-7-20210203","doi-asserted-by":"crossref","first-page":"5052","DOI":"10.1200\/JCO.2005.11.080","article-title":"Hodgkin\u2019s lymphoma in elderly patients: a comprehensive retrospective analysis from the German Hodgkin\u2019s Study Group.","volume":"23","author":"Engert","year":"2005","journal-title":"J Clin Oncol"},{"key":"R24-7-20210203","doi-asserted-by":"crossref","first-page":"7604","DOI":"10.1200\/JCO.2005.02.6310","article-title":"Epstein-Barr virus as a marker of survival after Hodgkin\u2019s lymphoma: a population-based study.","volume":"23","author":"Keegan","year":"2005","journal-title":"J Clin Oncol"},{"key":"R25-7-20210203","first-page":"261","article-title":"Risk patterns of Hodgkin\u2019s disease in Los Angeles vary by cell type.","volume":"1","author":"Cozen","year":"1992","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"R26-7-20210203","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s10552-007-9025-5","article-title":"The effect of atopy, childhood crowding, and other immune-related factors on non-Hodgkin\u2019s lymphoma risk.","volume":"18","author":"Cozen","year":"2007","journal-title":"Cancer Causes Control"},{"key":"R27-7-20210203","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1038\/sj.onc.1205418","article-title":"Gene expression profiling defines molecular subtypes of classicalal Hodgkin\u2019s disease.","volume":"21","author":"Devilard","year":"2002","journal-title":"Oncogene"},{"key":"R28-7-20210203","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1002\/1097-0142(19820501)49:9<1848::AID-CNCR2820490918>3.0.CO;2-Y","article-title":"Hodgkin\u2019s disease: a clinicopathologic study of 659 cases.","volume":"49","author":"Colby","year":"1981","journal-title":"Cancer"},{"key":"R29-7-20210203","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1200\/JCO.1989.7.11.1630","article-title":"Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin\u2019s disease: Cotswolds meeting.","volume":"7","author":"Lister","year":"1989","journal-title":"J Clin Oncol"},{"key":"R30-7-20210203","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1046\/j.1365-2559.2001.01083.x","article-title":"Interleukin-13 and interleukin-13 receptor in Hodgkin\u2019s disease: possible autocrine mechanism and involvement in fibrosis.","volume":"38","author":"Ohshima","year":"2001","journal-title":"Histopathology"},{"key":"R31-7-20210203","first-page":"569","article-title":"Production of transforming growth factor-beta activity by Ki-1 positive lymphoma cells and analysis of its role in the regulation of Ki-1 positive lymphoma growth.","volume":"131","author":"Newcom","year":"1988","journal-title":"Am J Pathol"},{"key":"R32-7-20210203","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1159\/000079723","article-title":"Lymphocyte populations in lymph nodes in different histological types of Hodgkin\u2019s disease in children.","volume":"112","author":"Pituch-Noworolska","year":"2004","journal-title":"Acta Haematol"},{"key":"R33-7-20210203","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1084\/jem.184.4.1495","article-title":"Hodgkin\u2019s and Reed-Sternberg cells in Hodgkin\u2019s disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells.","volume":"184","author":"Kanzler","year":"1996","journal-title":"J Exp Med"},{"key":"R34-7-20210203","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1182\/blood.V95.4.1443.004k55_1443_1450","article-title":"Hodgkin\u2019s and reed-sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription.","volume":"95","author":"Marafioti","year":"2000","journal-title":"Blood"},{"key":"R35-7-20210203","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/00000478-198607000-00004","article-title":"The \u201csyncytial variant\u201d of nodular sclerosing Hodgkin\u2019s disease.","volume":"10","author":"Strickler","year":"1986","journal-title":"Am J Surg Pathol"},{"key":"R36-7-20210203","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1002\/1097-0142(19900301)65:5<1167::AID-CNCR2820650523>3.0.CO;2-V","article-title":"Syncytial variant of nodular sclerosing Hodgkin\u2019s disease. A new clinicopathologic entity.","volume":"65","author":"Ben-Yehuda-Salz","year":"1990","journal-title":"Cancer"},{"key":"R37-7-20210203","doi-asserted-by":"crossref","first-page":"587","DOI":"10.7326\/0003-4819-92-5-587","article-title":"Curability of advanced Hodgkin\u2019s disease with chemotherapy. Long-term follow-up of MOPP-treated patients at the National Cancer Institute.","volume":"92","author":"DeVita","year":"1980","journal-title":"Ann Intern Med"},{"key":"R38-7-20210203","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1002\/1097-0142(197704)39:4<1439::AID-CNCR2820390414>3.0.CO;2-Z","article-title":"Radiotherapy results for nodular sclerosing Hodgkin\u2019s disease after clinical staging.","volume":"39","author":"Johnson","year":"1977","journal-title":"Cancer"},{"key":"R39-7-20210203","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0009-9260(83)80148-2","article-title":"The prognostic significance of cellular subtypes in nodular sclerosing Hodgkin\u2019s disease: an analysis of 271 non-laparotomised cases (BNLI report no. 22).","volume":"34","author":"Bennett","year":"1983","journal-title":"Clin Radiol"},{"key":"R40-7-20210203","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1002\/1097-0142(19891015)64:8<1686::AID-CNCR2820640822>3.0.CO;2-I","article-title":"Relationship of histopathologic features to survival and relapse in nodular sclerosing Hodgkin\u2019s disease.","volume":"64","author":"MacLennan","year":"1989","journal-title":"Cancer"},{"key":"R41-7-20210203","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1002\/1097-0142(19940715)74:2<708::AID-CNCR2820740226>3.0.CO;2-7","article-title":"Histopathologic grading of nodular sclerosis Hodgkin\u2019s disease. Lack of prognostic significance in 254 surgically staged patients.","volume":"74","author":"Hess","year":"1994","journal-title":"Cancer"},{"key":"R42-7-20210203","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/1097-0142(19930115)71:2<457::AID-CNCR2820710229>3.0.CO;2-U","article-title":"Hodgkin\u2019s disease, nodular sclerosis type. Implications of histologic subclassification.","volume":"71","author":"Ferry","year":"1993","journal-title":"Cancer"},{"key":"R43-7-20210203","first-page":"220","article-title":"Hodgkin\u2019s lymphomas: classification, diagnosis, and grading.","volume":"36","author":"Harris","year":"1999","journal-title":"Semin Hematol"},{"key":"R44-7-20210203","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1182\/blood-2002-05-1548","article-title":"Nodular sclerosing Hodgkin\u2019s disease: new grading predicts prognosis in intermediate and advanced stages.","volume":"101","author":"von Wasielewski","year":"2003","journal-title":"Blood"},{"key":"R45-7-20210203","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1084\/jem.20031074","article-title":"Molecular diagnosis of primary mediastinal B cell lymphoma identifies a clinically favorable subgroup of diffuse large B cell lymphoma related to Hodgkin\u2019s lymphoma.","volume":"198","author":"Rosenwald","year":"2003","journal-title":"J Exp Med"},{"key":"R46-7-20210203","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1182\/blood-2003-06-1841","article-title":"The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classicalal Hodgkin\u2019s lymphoma.","volume":"102","author":"Savage","year":"2003","journal-title":"Blood"},{"key":"R47-7-20210203","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1097\/01.pas.0000180856.74572.73","article-title":"Mediastinal gray zone lymphoma: the missing link between classical Hodgkin\u2019s lymphoma and mediastinal large B-cell lymphoma.","volume":"29","author":"Traverse-Glehen","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"R48-7-20210203","first-page":"735","article-title":"Discordant expression of immunoglobulin and its associated molecule mb-1\/CD79a is frequently found in mediastinal large B-cell lymphomas.","volume":"146","author":"Kanavaros","year":"1995","journal-title":"Am J Pathol"},{"key":"R49-7-20210203","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1097\/01.MP.0000032534.81894.B3","article-title":"MAL expression in lymphoid cells: further evidence for MAL as a distinct molecular marker of primary mediastinal large B-cell lymphomas.","volume":"15","author":"Copie-Bergman","year":"2002","journal-title":"Mod Pathol"},{"key":"R50-7-20210203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1309\/98KLHRDAM5CMDHE2","article-title":"MAL is expressed in a subset of Hodgkin\u2019s lymphoma and identifies a population of patients with poor prognosis.","volume":"125","author":"Hsi","year":"2006","journal-title":"Am J Clin Pathol"},{"key":"R51-7-20210203","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1365-2141.1994.tb04781.x","article-title":"Anaplastic large cell lymphoma (CD30+\/Ki-1+): results of a prospective clinicopathologic study of 69 cases.","volume":"86","author":"Pileri","year":"1994","journal-title":"Br J Haematol"},{"key":"R52-7-20210203","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/modpathol.3880289","article-title":"Anaplastic large cell lymphoma: the shifting sands of diagnostic hematopathology.","volume":"14","author":"Jaffe","year":"2001","journal-title":"Mod Pathol"},{"key":"R53-7-20210203","first-page":"790","article-title":"Anaplastic large cell lymphoma Hodgkin\u2019s-like: a randomized trial of ABVD versus MACOP-B with and without radiation therapy.","volume":"92","author":"Zinzani","year":"1998","journal-title":"Blood"},{"key":"R54-7-20210203","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/00000478-200103000-00003","article-title":"Pathologic and clinical features of 77 Hodgkin\u2019s lymphoma patients treated in a lymphoma protocol (LNH87): a GELA study.","volume":"25","author":"Cazals-Hatem","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R55-7-20210203","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1182\/blood.V112.11.3590.3590","article-title":"Gray zone lymphomas: clinical and histological characteristics and treatment with dose-adjusted EPOCH-R.","volume":"112","author":"Dunleavy","year":"2008","journal-title":"Blood"},{"key":"R56-7-20210203","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/1097-0142(19950315)75:6<1360::AID-CNCR2820750619>3.0.CO;2-U","article-title":"Hodgkin\u2019s disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype.","volume":"75","author":"Zarate-Osorno","year":"1995","journal-title":"Cancer"},{"key":"R57-7-20210203","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1182\/blood.V81.2.462.462","article-title":"Epstein-Barr virus and childhood Hodgkin\u2019s disease in Honduras and the United States.","volume":"81","author":"Ambinder","year":"1993","journal-title":"Blood"},{"key":"R58-7-20210203","first-page":"651","article-title":"Hodgkin\u2019s lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore.","volume":"7","author":"Siddiqui","year":"2006","journal-title":"Asian Pac J Cancer Prev"},{"key":"R59-7-20210203","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1097\/00001622-200109000-00007","article-title":"Epidemiologic trends in HIV-associated lymphomas.","volume":"13","author":"Clarke","year":"2001","journal-title":"Curr Opin Oncol"},{"key":"R60-7-20210203","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/cncr.11459","article-title":"Population-based patterns of human immunodeficiency virus-related Hodgkin\u2019s lymphoma in the Greater San Francisco Bay Area, 1988\u20131998.","volume":"98","author":"Glaser","year":"2003","journal-title":"Cancer"},{"key":"R61-7-20210203","doi-asserted-by":"crossref","first-page":"3786","DOI":"10.1182\/blood-2006-05-024109","article-title":"Hodgkin\u2019s lymphoma and immunodeficiency in persons with HIV\/AIDS.","volume":"108","author":"Biggar","year":"2006","journal-title":"Blood"},{"key":"R62-7-20210203","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1002\/ijc.23391","article-title":"The spectrum of human immunodeficiency virus-associated cancers in a South African black population: results from a case-control study, 1995\u20132004.","volume":"122","author":"Stein","year":"2008","journal-title":"Int J Cancer"},{"key":"R63-7-20210203","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1056\/NEJM197304122881502","article-title":"Lymphocyte-depletion Hodgkin\u2019s disease. A clinicopathological entity.","volume":"288","author":"Neiman","year":"1973","journal-title":"N Engl J Med"},{"key":"R64-7-20210203","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1002\/1097-0142(197206)29:6<1481::AID-CNCR2820290611>3.0.CO;2-V","article-title":"Prognostic indicators in Hodgkin\u2019s disease.","volume":"29","author":"Axtell","year":"1972","journal-title":"Cancer"},{"key":"R65-7-20210203","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1200\/JCO.1986.4.3.284","article-title":"The pathologic and clinical heterogeneity of lymphocyte-depleted Hodgkin\u2019s disease.","volume":"4","author":"Kant","year":"1986","journal-title":"J Clin Oncol"},{"key":"R66-7-20210203","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/cncr.21995","article-title":"Hodgkin\u2019s disease survival in Europe and the U.S.: prognostic significance of morphologic groups.","volume":"107","author":"Allemani","year":"2006","journal-title":"Cancer"},{"key":"R67-7-20210203","first-page":"1189","article-title":"Epidemiology of Hodgkin\u2019s disease.","volume":"26","author":"MacMahon","year":"1966","journal-title":"Cancer Res"},{"key":"R68-7-20210203","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1056\/NEJM197010152831609","article-title":"Isolated granulomas in Hodgkin\u2019s disease.","volume":"283","author":"Kadin","year":"1970","journal-title":"N Engl J Med"},{"key":"R69-7-20210203","first-page":"1063","article-title":"The pathology and nomenclature of Hodgkin\u2019s disease.","volume":"26","author":"Lukes","year":"1966","journal-title":"Cancer Res"},{"key":"R70-7-20210203","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1111\/j.1365-2559.2005.02175.x","article-title":"Large B-cell lymphoma with Hodgkin\u2019s features.","volume":"47","author":"Garcia","year":"2005","journal-title":"Histopathology"},{"key":"R71-7-20210203","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00000478-200301000-00003","article-title":"Senile EBV+ B-cell lymphoproliferative disorders: a clinicopathologic study of 22 patients.","volume":"27","author":"Oyama","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R72-7-20210203","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1182\/blood-2007-01-067769","article-title":"The impact of Epstein-Barr virus status on clinical outcome in diffuse large B-cell lymphoma.","volume":"110","author":"Park","year":"2007","journal-title":"Blood"},{"key":"R73-7-20210203","first-page":"1889","article-title":"European Task Force on Lymphoma project on lymphocyte predominance Hodgkin\u2019s disease: histologic and immunohistologic analysis of submitted cases reveals 2 types of Hodgkin\u2019s disease with a nodular growth pattern and abundant lymphocytes.","volume":"96","author":"Anagnostopoulos","year":"2000","journal-title":"Blood"},{"key":"R74-7-20210203","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1200\/JCO.1999.17.3.776","article-title":"Clinical presentation, course, and prognostic factors in lymphocyte- predominant Hodgkin\u2019s disease and lymphocyte-rich classicalal Hodgkin\u2019s disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin\u2019s Disease.","volume":"17","author":"Diehl","year":"1999","journal-title":"J Clin Oncol"},{"key":"R75-7-20210203","first-page":"2220","article-title":"Lymphocyte-rich classicalal Hodgkins lymphoma: clinical presentation and treatment outcome in 100 patients treated within German Hodgkins Study Group trials (vol 23, pg 5739, 2005).","volume":"24","author":"Shimabukuro","year":"2006","journal-title":"J Clin Oncol"},{"key":"R76-7-20210203","first-page":"1644","article-title":"Typing the histogenetic origin of the tumor cells of lymphocyte-rich classicalal Hodgkin\u2019s lymphoma in relation to tumor cells of classicalal and lymphocyte-predominance Hodgkin\u2019s lymphoma.","volume":"63","author":"Brauninger","year":"2003","journal-title":"Cancer Res"},{"key":"R77-7-20210203","first-page":"1294","article-title":"Follicular Hodgkin\u2019s disease.","volume":"19","author":"Ashton-Key","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"R78-7-20210203","first-page":"57","article-title":"Histologische Klassifizierung and Vorkommen des M.","volume":"15","author":"Lennert","year":"1974","journal-title":"Hodgkin\u2019s Internist"},{"key":"R79-7-20210203","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.humpath.2005.05.003","article-title":"Epstein-Barr virus is associated with all histological subtypes of Hodgkin\u2019s lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype.","volume":"36","author":"Chang","year":"2005","journal-title":"Hum Pathol"},{"key":"R80-7-20210203","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1056\/NEJM198801283180404","article-title":"Nodular and diffuse types of lymphocyte predominance Hodgkin\u2019s disease.","volume":"318","author":"Regula","year":"1988","journal-title":"N Engl J Med"},{"key":"R81-7-20210203","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1097\/00000478-200310000-00007","article-title":"Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.","volume":"27","author":"Fan","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R82-7-20210203","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/BF02889938","article-title":"Nodular paragranuloma and progressively transformed germinal centers: ultrastructural and immunohistochemical findings.","volume":"31","author":"Poppema","year":"1979","journal-title":"Virchows Arch [B]"},{"key":"R83-7-20210203","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00000478-199203000-00005","article-title":"Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin\u2019s disease.","volume":"16","author":"Ferry","year":"1992","journal-title":"Am J Surg Pathol"},{"key":"R84-7-20210203","first-page":"599","article-title":"Lymphocyte predominant Hodgkin\u2019s disease, nodular subtype with coexistent \u201clarge cell lymphoma.\u201d Histological progression or composite malignancy?","volume":"12","author":"Sundeen","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"R85-7-20210203","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/S0046-8177(89)80007-3","article-title":"Nodular paragranuloma can transform into high-grade malignant lymphoma of B type.","volume":"20","author":"Hansmann","year":"1989","journal-title":"Hum Pathol"},{"key":"R86-7-20210203","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1080\/1042819031000149421","article-title":"Diffuse large B-cell lymphoma arising in nodular lymphocyte predominant Hodgkin\u2019s lymphoma: a report of 21 cases from the Nebraska Lymphoma Study Group.","volume":"45","author":"Huang","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"R87-7-20210203","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1182\/blood.V88.2.657.bloodjournal882657","article-title":"Nodular lymphocyte-predominant Hodgkin\u2019s disease associated with large-cell lymphoma: analysis of Ig gene rearrangements by V-J polymerase chain reaction.","volume":"88","author":"Greiner","year":"1996","journal-title":"Blood"},{"key":"R88-7-20210203","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1182\/blood.V86.6.2312.bloodjournal8662312","article-title":"Clonal relationship between lymphocytic predominance Hodgkin\u2019s disease and concurrent or subsequent large-cell lymphoma of B lineage.","volume":"86","author":"Wickert","year":"1995","journal-title":"Blood"},{"key":"R89-7-20210203","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/annonc\/13.S1.44","article-title":"Workshop on the relationship between nodular lymphocyte predominant Hodgkin\u2019s lymphoma and T cell\/histiocyte-rich B cell lymphoma.","volume":"13","author":"Rudiger","year":"2002","journal-title":"Ann Oncol"},{"key":"R90-7-20210203","first-page":"24","article-title":"Nodular lymphocyte predominant Hodgkin\u2019s lymphoma with nodules resembling T-cell\/histiocyte rich B-cell lymphoma: differential diagnosis between nodular lymphocyte predominant Hodgkin\u2019s lymphoma and T-cell\/histiocyte rich B-cell lymphoma.","volume":"24","author":"Boudova","year":"2003","journal-title":"Blood"},{"key":"R91-7-20210203","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1002\/ijc.2910300411","article-title":"Identification of Hodgkin\u2019s and Sternberg-reed cells as a unique cell type derived from a newly-detected small-cell population.","volume":"30","author":"Stein","year":"1982","journal-title":"Int J Cancer"},{"key":"R92-7-20210203","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/0090-3019(96)00033-X","article-title":"Primary Ki-1-positive T-cell lymphoma of the brain\u2013an aggressive subtype of lymphoma: case report and review of the literature.","volume":"46","author":"Goldbrunner","year":"1996","journal-title":"Surg Neurol"},{"key":"R93-7-20210203","first-page":"209","article-title":"Phenotypic expression of Hodgkin\u2019s and Reed-Sternberg cells in Hodgkin\u2019s disease.","volume":"118","author":"Hsu","year":"1985","journal-title":"Am J Pathol"},{"key":"R94-7-20210203","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/00000478-198801000-00002","article-title":"Monoclonal antibodies in the diagnosis of Hodgkin\u2019s disease. The search for a rational panel.","volume":"12","author":"Chittal","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"R95-7-20210203","first-page":"1381","article-title":"Prognostic significance of CD20 expression in classicalal Hodgkin\u2019s lymphoma: a clinicopathological study of 119 cases.","volume":"9","author":"Tzankov","year":"2003","journal-title":"Clin Cancer Res"},{"key":"R96-7-20210203","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1182\/blood-2002-03-0839","article-title":"Loss of the B-lineage-specific gene expression program in Hodgkin\u2019s and Reed-Sternberg cells of Hodgkin\u2019s lymphoma.","volume":"101","author":"Schwering","year":"2003","journal-title":"Blood"},{"key":"R97-7-20210203","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1056\/NEJM198902233200806","article-title":"Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin\u2019s disease.","volume":"320","author":"Weiss","year":"1989","journal-title":"N Engl J Med"},{"key":"R98-7-20210203","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1182\/blood-2007-01-066100","article-title":"Galectin-1 mediated suppression of Epstein-Barr virus specific T-cell immunity in classical Hodgkin\u2019s lymphoma.","volume":"110","author":"Gandhi","year":"2007","journal-title":"Blood"},{"key":"R99-7-20210203","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1093\/ajcp\/86.3.292","article-title":"Reed-Sternberg and Hodgkin\u2019s cells in lymphocyte-predominant Hodgkin\u2019s disease of nodular subtype contain J chain.","volume":"86","author":"Stein","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"R100-7-20210203","first-page":"1281","article-title":"L and H cells of nodular lymphocyte predominant Hodgkin\u2019s disease show immunoglobulin light-chain restriction.","volume":"139","author":"Schmid","year":"1991","journal-title":"Am J Pathol"},{"key":"R101-7-20210203","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/01.pas.0000194741.87798.45","article-title":"IgD Positive L&H Cells Identify a Unique Subset of Nodular Lymphocyte Predominant Hodgkin\u2019s Lymphoma.","volume":"30","author":"Prakash","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R102-7-20210203","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1182\/blood.V94.9.3108","article-title":"Frequent expression of the B-cell-specific activator protein in Reed-Sternberg cells of classicalal Hodgkin\u2019s disease provides further evidence for its B-cell origin.","volume":"94","author":"Foss","year":"1999","journal-title":"Blood"},{"key":"R103-7-20210203","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1182\/blood.V97.2.496","article-title":"Down-regulation of BOB. 1\/OBF. 1 and Oct2 in classicalal Hodgkin\u2019s disease but not in lymphocyte predominant Hodgkin\u2019s disease correlates with immunoglobulin transcription.","volume":"97","author":"Stein","year":"2001","journal-title":"Blood"},{"key":"R104-7-20210203","first-page":"957","article-title":"Leukocyte-specific phosphoprotein-1 and PU. 1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin\u2019s disease.","volume":"89","author":"Marafioti","year":"2004","journal-title":"Haematologica"},{"key":"R105-7-20210203","first-page":"1123","article-title":"Classical Hodgkin\u2019s disease. Clinical impact of the immunophenotype.","volume":"151","author":"von Wasielewski","year":"1997","journal-title":"Am J Pathol"},{"key":"R106-7-20210203","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1111\/j.1365-2141.2004.04964.x","article-title":"Adverse prognostic significance of CD20 positive Reed-Sternberg cells in classicalal Hodgkin\u2019s disease.","volume":"125","author":"Portlock","year":"2004","journal-title":"Br J Haematol"},{"key":"R107-7-20210203","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1038\/modpathol.3800473","article-title":"Rare expression of T-cell markers in classicalal Hodgkin\u2019s lymphoma.","volume":"18","author":"Tzankov","year":"2005","journal-title":"Mod Pathol"},{"key":"R108-7-20210203","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.it.2006.03.001","article-title":"Reprogramming of the tumour B-cell phenotype in Hodgkin\u2019s lymphoma.","volume":"27","author":"Kuppers","year":"2006","journal-title":"Trends Immunol"},{"key":"R109-7-20210203","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.191.2.387","article-title":"Rare occurrence of classicalal Hodgkin\u2019s disease as a T cell lymphoma.","volume":"191","author":"Muschen","year":"2000","journal-title":"J Exp Med"},{"key":"R110-7-20210203","doi-asserted-by":"crossref","first-page":"3020","DOI":"10.1182\/blood.V95.10.3020","article-title":"Detection of clonal T-cell receptor gamma-chain gene rearrangements in Reed-Sternberg cells of classical Hodgkin\u2019s disease.","volume":"95","author":"Seitz","year":"2000","journal-title":"Blood"},{"key":"R111-7-20210203","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1097\/00000478-200312000-00003","article-title":"Peripheral T-cell lymphomas expressing CD30 and CD15.","volume":"27","author":"Barry","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R112-7-20210203","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1056\/NEJM199204233261704","article-title":"Hodgkin\u2019s disease, lymphomatoid papulosis, and cutaneous T-cell lymphoma derived from a common T-cell clone.","volume":"326","author":"Davis","year":"1992","journal-title":"N Engl J Med"},{"key":"R113-7-20210203","first-page":"457","article-title":"Nodular lymphocyte predominance type of Hodgkin\u2019s disease is a germinal center lymphoma.","volume":"54","author":"Timmens","year":"1986","journal-title":"Lab Invest"},{"key":"R114-7-20210203","first-page":"541","article-title":"Leu 7 (CD57) reactivity distinguishes nodular lymphocyte predominance Hodgkin\u2019s disease from nodular sclerosing Hodgkin\u2019s disease, T-cell-rich B-cell lymphoma and follicular lymphoma.","volume":"142","author":"Kamel","year":"1993","journal-title":"Am J Pathol"},{"key":"R115-7-20210203","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1097\/PAS.0b013e318165b0d6","article-title":"PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin\u2019s lymphoma.","volume":"32","author":"Nam-Cha","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"R116-7-20210203","first-page":"229","article-title":"Reed-Sternberg cell: survival in a hostile sea.","volume":"78","author":"Cossman","year":"1998","journal-title":"Lab Invest"},{"key":"R117-7-20210203","doi-asserted-by":"crossref","first-page":"5716","DOI":"10.1158\/0008-5472.CAN-06-0261","article-title":"Specific recruitment of CC chemokine receptor 4-positive regulatory T cells in Hodgkin\u2019s lymphoma fosters immune privilege.","volume":"66","author":"Ishida","year":"2006","journal-title":"Cancer Res"},{"key":"R118-7-20210203","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1182\/blood-2003-07-2594","article-title":"Immunosuppressive regulatory T cells are abundant in the reactive lymphocytes of Hodgkin\u2019s lymphoma.","volume":"103","author":"Marshall","year":"2004","journal-title":"Blood"}],"container-title":["The Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/PPO.0b013e31819e31cf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:14:34Z","timestamp":1786040074000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00130404-200904000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,3]]},"references-count":118,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1097\/ppo.0b013e31819e31cf","relation":{},"ISSN":["1528-9117"],"issn-type":[{"value":"1528-9117","type":"print"}],"subject":[],"published":{"date-parts":[[2009,3]]}}}